Reducing TNF Receptor 2 + Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1576
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2013
Authors
Publisher
American Association for Cancer Research (AACR)